Sylvia Bele Selected Research

Nimodipine (Modus)

5/2022	Fight INflammation to Improve outcome after aneurysmal Subarachnoid HEmorRhage (FINISHER) trial: Study protocol for a randomized controlled trial.
2/2022	Continuous intra-arterial nimodipine infusion as rescue treatment of severe refractory cerebral vasospasm after aneurysmal subarachnoid hemorrhage.
1/2019	Incidence of Arterial Hypotension in Patients Receiving Peroral or Continuous Intra-arterial Nimodipine After Aneurysmal or Perimesencephalic Subarachnoid Hemorrhage.
1/2018	Side Effects of Long-Term Continuous Intra-arterial Nimodipine Infusion in Patients with Severe Refractory Cerebral Vasospasm after Subarachnoid Hemorrhage.
12/2015	Continuous intra-arterial nimodipine infusion in patients with severe refractory cerebral vasospasm after aneurysmal subarachnoid hemorrhage: a feasibility study and outcome results.
7/2014	[Case report: Aneurysmatic subarachnoid hemorrhage -- complicated course due to coincidental manifestation of an inverted Tako-Tsubo-cardiomyopathy].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Sylvia Bele Research Topics

Disease

14	Subarachnoid Hemorrhage (Aneurysmal Subarachnoid Hemorrhage) 05/2022 - 01/2010
10	Intracranial Vasospasm 02/2022 - 04/2013
6	Brain Ischemia (Cerebral Ischemia) 09/2021 - 07/2014
2	Aneurysm (Aneurysms) 05/2022 - 12/2018
2	Hemorrhage 05/2022 - 12/2018
2	Cerebral Infarction 02/2022 - 12/2015
2	Infarction (Infarctions) 02/2022 - 06/2017
2	Infections 08/2021 - 04/2012
2	Disease Progression 01/2018 - 04/2013
2	Acute Kidney Injury (Acute Renal Failure) 01/2018 - 01/2017
2	Hydrocephalus (Hydrocephaly) 06/2017 - 04/2012
2	Critical Illness (Critically Ill) 01/2017 - 04/2012
2	Stroke (Strokes) 12/2013 - 08/2011
1	Inflammation (Inflammations) 05/2022
1	Pneumonia (Pneumonitis) 08/2021
1	Sepsis (Septicemia) 08/2021
1	Urinary Tract Infections (Urinary Tract Infection) 08/2021
1	Hyponatremia 06/2021
1	Hypercapnia 08/2019
1	Hypotension (Low Blood Pressure) 01/2019
1	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 12/2018
1	Pain (Aches) 12/2018
1	Mental Disorders (Mental Disorder) 12/2018
1	Heart Arrest (Cardiac Arrest) 01/2018
1	Traumatic Subarachnoid Hemorrhage 01/2018
1	Cerebral Hemorrhage 07/2017
1	Poisoning 06/2017
1	Carbon Monoxide Poisoning (Poisoning, Carbon Monoxide) 06/2017
1	Craniocerebral Trauma (Head Injury) 01/2015
1	Ischemia 04/2013
1	Surgical Blood Loss 04/2012
1	Wound Infection (Wound Infections) 04/2012

Drug/Important Bio-Agent (IBA)

6	Nimodipine (Modus)FDA LinkGeneric 05/2022 - 07/2014
5	Neuropeptide YIBA 12/2018 - 08/2011
3	Vasoconstrictor AgentsIBA 12/2018 - 08/2011
2	Oxygen (Dioxygen)IBA 09/2021 - 01/2015
2	Calcitonin Gene-Related PeptideIBA 06/2021 - 04/2013
2	EnzymesIBA 12/2018 - 04/2013
1	Dexamethasone (Maxidex)FDA LinkGeneric 05/2022
1	FludrocortisoneIBA 06/2021
1	Vasodilator Agents (Vasodilators)IBA 06/2021
1	Tolvaptan FDA Link 06/2021
1	SodiumIBA 06/2021
1	Sodium Chloride FDA LinkGeneric 06/2021
1	1-phenyl-3,3-dimethyltriazene (PDT)IBA 08/2019
1	Carbon MonoxideIBA 06/2017
1	Starch (Cornstarch)IBA 01/2017
1	SolutionsIBA 01/2017
1	Biomarkers (Surrogate Marker)IBA 12/2013
1	NeuropeptidesIBA 04/2013
1	Phosphopyruvate Hydratase (Enolase)IBA 01/2010
1	Proteins (Proteins, Gene)FDA Link 01/2010

Therapy/Procedure

4	Therapeutics 05/2022 - 07/2014
1	Craniotomy 02/2022
1	Tracheotomy 02/2022
1	Decompressive Craniectomy 02/2022
1	Catheters 08/2021
1	Aftercare (After-Treatment) 12/2018
1	Hybrid Renal Replacement Therapy 01/2018
1	Resuscitation 01/2018
1	Renal Replacement Therapy (Therapies, Renal Replacement) 01/2018
1	Hyperbaric Oxygenation 06/2017
1	Ventriculostomy 04/2012
1	Operative Surgical Procedures 04/2012